Pfizer Inc. (PFE) – Financial and Strategic SWOT Analysis Review

Pfizer Inc. (PFE) – Financial and Strategic SWOT Analysis Review Cover

Single Licence: $125

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
109
Pharmaceuticals and Healthcare
United States

Pfizer Inc. (PFE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. It focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. The company’s product offerings are targeted against a wide range of therapeutic areas including respiratory, cardiovascular, metabolic, infection, inflammation, oncology, ophthalmology, neuroscience, pain, tissue repair, gastrointestinal, women’s health, orphan diseases and genitourinary among others. The company’s research and development activities focus on developing small molecules, biologics and vaccines. The company operates through a network of subsidiaries and affiliates located across the world. Pfizer is headquartered in New York, the US.

The key business strategies of the company include the enhanced focus on developing and delivering innovative medicines that help patients throughout the world. The company aims to achieve flexibility and optimum operational efficiency in its manufacturing and production to cater to diverse needs of its clients in an efficient manner.

Pfizer Inc. Key Recent Developments

Mar 10, 2015: Pfizer Reverses Its Decision To Close Little Island Facility
Feb 24, 2015: Pfizer To Reduce Workforce At Cambridge Research Center
Feb 04, 2015: Pfizer Marks World Cancer Day With Grant To Union For International Cancer Control To Address The Needs Of Metastatic Breast Cancer Patients
Jan 27, 2015: Pfizer Reports Fourth-Quarter And Full-Year 2014 Results; Provides 2015 Financial Guidance
Jan 21, 2015: Pfizer and the Avon Foundation for Women Award 23 Grants Totaling $1 Million in Funding to Support Patients Living With Metastatic Breast Cancer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Table of Contents

Section 1 – About the Company 6
Pfizer Inc. – Key Facts 6
Pfizer Inc. – Key Employees 7
Pfizer Inc. – Key Employee Biographies 9
Pfizer Inc. – Major Products and Services 10
Pfizer Inc. – Pharmaceutical Pipeline Products Data 12
Pfizer Inc., Pipeline Products by Therapy Area 12
Pfizer Inc., Pipeline Products by Development Phase 13
Pfizer Inc. – History 26
Pfizer Inc. – Company Statement 43
Pfizer Inc. – Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Joint Venture 72
Section 2 – Company Analysis 73
Pfizer Inc. – Business Description 73
Pfizer Inc. – Corporate Strategy 75
Pfizer Inc. – SWOT Analysis 76
SWOT Analysis – Overview 76
Pfizer Inc. – Strengths 76
Strength – Leading Biopharmaceutical Products 76
Strength – Growing VOC segment 76
Strength – In-house Research Expertise 76
Pfizer Inc. – Weaknesses 78
Weakness – Product Defects 78
Weakness – Discontinued Projects 78
Weakness – Declined Operational Performance 78
Pfizer Inc. – Opportunities 79
Opportunity – Promising Product Pipeline 79
Opportunity – Significant Agreements and Collaboration 79
Opportunity – Strategic Acquisitions 79
Pfizer Inc. – Threats 80
Threat – Competitive Landscape 80
Threat – Government Regulations 80
Threat – Patent Expiry 80
Pfizer Inc. – Key Competitors 81
Section 3 – Company Financial Ratios 82
Financial Ratios – Capital Market Ratios 82
Financial Ratios – Annual Ratios 83
Performance Chart 85
Financial Performance 85
Financial Ratios – Interim Ratios 86
Financial Ratios – Ratio Charts 87
Section 4 – Company’s Lifesciences Financial Deals and Alliances 88
Pfizer Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 88
Pfizer Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 89
Pfizer Inc., Recent Deals Summary 90
Section 5 – Company’s Recent Developments 91
Mar 10, 2015: Pfizer Reverses Its Decision To Close Little Island Facility 91
Feb 24, 2015: Pfizer To Reduce Workforce At Cambridge Research Center 92
Feb 04, 2015: Pfizer Marks World Cancer Day With Grant To Union For International Cancer Control To Address The Needs Of Metastatic Breast Cancer Patients 93
Jan 27, 2015: Pfizer Reports Fourth-Quarter And Full-Year 2014 Results; Provides 2015 Financial Guidance 94
Jan 21, 2015: Pfizer and the Avon Foundation for Women Award 23 Grants Totaling $1 Million in Funding to Support Patients Living With Metastatic Breast Cancer 99
Jan 19, 2015: MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5 per child for poor countries ahead of donor meeting 100
Jan 15, 2015: Pfizer To Layoff 50 Workers At Pearl River Plant In New York 101
Jan 13, 2015: Pfizer Provides Update On Development Of Cholesterol Lowering Pill And Vaccine 102
Jan 12, 2015: 23andMe Announces Collaboration with Pfizer to Conduct Genetic Research Through 23andMe’s Research Platform 103
Dec 15, 2014: Pfizer Declares First-Quarter 2015 Dividend 104
Section 6 – Appendix 105
Methodology 105
Ratio Definitions 105
About GlobalData 109
Contact Us 109
Disclaimer 109



List of Tables
Pfizer Inc., Key Facts 6
Pfizer Inc., Key Employees 7
Pfizer Inc., Key Employee Biographies 9
Pfizer Inc., Major Products and Services 10
Pfizer Inc., Number of Pipeline Products by Therapy Area 12
Pfizer Inc., Number of Pipeline Products by Development Stage 13
Pfizer Inc., Pipeline Products By Therapy Area and Development Phase 14
Pfizer Inc., History 26
Pfizer Inc., Other Locations 47
Pfizer Inc., Subsidiaries 47
Pfizer Inc., Joint Venture 72
Pfizer Inc., Key Competitors 81
Pfizer Inc., Ratios based on current share price 82
Pfizer Inc., Annual Ratios 83
Pfizer Inc., Interim Ratios 86
Pfizer Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 88
Pfizer Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 89
Pfizer Inc., Recent Deals Summary 90
Currency Codes 105
Capital Market Ratios 105
Equity Ratios 106
Profitability Ratios 106
Cost Ratios 107
Liquidity Ratios 107
Leverage Ratios 108
Efficiency Ratios 108



List of Figures
Pfizer Inc., Pipeline Products by Therapy Area 12
Pfizer Inc., Pipeline Products by Development Phase 13
Pfizer Inc., Performance Chart (2010 – 2014) 85
Pfizer Inc., Ratio Charts 87
Pfizer Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 88
Pfizer Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 89

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $125

Report Licences Explanation

* Single User: Electronic PDF copy delivered via email. Report can be used by individual purchaser only.

* Site License: Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.

* Enterprise Wide License: Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.

If you require a Site License or Enterprise Wide License please contact us to issue you an invoice.

Customers who Viewed this Report also Viewed

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.